EGI
CTSO icon

EAM Global Investors’s Cytosorbents Corp CTSO Stock Holding History

EAM Global Investors’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-114,109
Closed -$1.13M – 146
2020
Q2 		$1.13M Buy
114,109
+52,314
+85% +$480K 0.51% 95
2020
Q1 		$478K Buy
+61,795
New +$312K 0.28% 98
2019
Q1 		– Sell
-78,027
Closed -$630K – 136
2018
Q4 		$630K Sell
78,027
-22,413
-22% -$223K 0.34% 124
2018
Q3 		$1.3M Sell
100,440
-19,366
-16% -$243K 0.53% 105
2018
Q2 		$1.37M Buy
+119,806
New +$1.13M 0.67% 64

Other funds holding CTSO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

EAM Global Investors's CTSO Position: Q3 2020 in Review

EAM Global Investors sold out of Cytosorbents Corp (CTSO) in Q3 2020, closing a stake of 114,109 shares — an estimated $1.13M sold.

EAM Global Investors first reported a position in CTSO in Q2 2018 and held it in 5 quarters. The position peaked at $1.37M in Q2 2018. 96 funds tracked by Wall St. Rank hold CTSO as of Q3 2020.

  • EAM Global Investors reported no remaining Cytosorbents Corp position as of Q3 2020 after selling out during the quarter.
  • EAM Global Investors sold 114,109 Cytosorbents Corp shares in Q3 2020, an estimated $1.13M.
  • EAM Global Investors first reported a position in Cytosorbents Corp in Q2 2018 and held it in 5 quarters.
  • EAM Global Investors's Cytosorbents Corp position peaked at $1.37M in Q2 2018.
  • 96 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q3 2020.

Based on EAM Global Investors's 13F filing for Q3 2020, filed 13 Nov 2020.